Support for development of proposals for EU funding for health research (HELSE-EU)

NOK 16 million for collaboration to develop project proposals in areas of strategic importance for health research under Horizon 2020. This call for proposals will be made active at the end of August 2017. 

Link to the call

 

Guidelines and important considerations relevant to all types of applications in this call for proposals:

The following thematic areas have been defined by the Research Council as being of particular strategic importance. The application must involve cooperation within one of these thematic areas:

research and development that makes use of health registry data (and/or biobank data);

research and development in the field of personalised medicine;

research and development on ICT technology for better health (eHealth, mHealth, welfare technology, telemedicine);

research and development on health services;

research and development targeting implementation, raising capacity and/or rolling out interventions for better health;

research and development targeting infectious diseases, antimicrobial resistance and the EU One Health Action Plan;

research and development targeting neurodegenerative diseases;

clinical treatment Research.


Participants in the collaboration:

Collaboration must encompass actors across institutions, research groups, disciplines, subject areas and/or sectors. Applicants may come from trade and industry, research institutes, universities, university colleges, regional health authorities, public sector entities, and user organisations. Applicants should have close scientific contacts with relevant European research groups. Partners or project managers who have already received funding for collaborative projects under the HELSE-EU scheme may not be granted support for new Projects.


Additional guidelines

Collaboration on the thematic areas under the HELSE-EU scheme is to lead to the submission of one or more proposals under Horizon 2020 or affiliated activities such as the Innovative Medicines Initiative (IMI), the European & Developing Countries Clinical Trials Partnership (EDCTP) and the Active and Assisted Living Joint Programme (AAL JP).

Funding is to be used to strengthen or expand existing collaboration or establish new collaboration between national actors.

Collaboration is to increase each participant’s ability to compete successfully for Horizon 2020 funding, either as a member of a consortium or through individual proposals.

Collaboration is to increase the likelihood that the partners, together or separately, will be included in other excellent consortia that compete successfully for Horizon 2020 funding.

The collaborating group is encouraged to develop international alliances that in the long term increase the likelihood of achieving leading roles in international consortia.

Collaboration may include sharing of best practice, exchanging knowledge and data and other activities that enable the participants to expand their expertise and that better equip them to compete successfully for Horizon 2020 funding.

The collaboration may include all or segments of pre-projects, pilot projects or demo projects whose results provide the basis for a larger Horizon 2020-funded Project.


The budget may include expenses for positions, project costs, payroll compensation for clinical personnel, travel expenses and costs in connection with meetings and other activities that strengthen the collaboration and increase the likelihood of winning Horizon 2020 funding.

Amount of funding presumed available for this call for proposals

Up to NOK 8 million annually.

Each collaborative project may receive up to NOK 1 million per year for up to two years.

Published July 19, 2017 10:25 AM - Last modified July 19, 2017 10:25 AM